Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Jacobson Pharma Corporation Limited ( (HK:2633) ).
Jacobson Pharma Corporation Limited has announced its upcoming annual general meeting to be held virtually on July 28, 2025. Key agenda items include the approval of financial statements, declaration of final and special dividends, re-election of directors, and the reappointment of KPMG as auditor. Additionally, the company seeks shareholder approval for a mandate to repurchase up to 10% of its issued shares, which could impact the company’s stock liquidity and shareholder value.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, production, and distribution of generic drugs and proprietary medicines. It operates primarily in the healthcare industry, serving markets with a range of pharmaceutical products.
Average Trading Volume: 1,286,846
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.1B
See more data about 2633 stock on TipRanks’ Stock Analysis page.